BIETTI CRYSTALLINE DYSTROPHY

Clinical trials for BIETTI CRYSTALLINE DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new BIETTI CRYSTALLINE DYSTROPHY trials appear

Sign up with your email to follow new studies for BIETTI CRYSTALLINE DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Not yet finished but already full! 2

Gene therapy expands to second eye in rare vision loss trial

Disease control Not yet recruiting

This study tests a gene therapy called VGR-R01 in the second eye of 15 people with Bietti's crystalline dystrophy, a rare inherited eye disease that causes vision loss. Participants already received the therapy in one eye in a previous study. The main goal is to check safety, and…

Matched conditions: BIETTI CRYSTALLINE DYSTROPHY

Phase: PHASE1, PHASE2 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control

Last updated May 22, 2026 13:53 UTC

BIETTI CRYSTALLINE DYSTROPHY

Get alerted when new BIETTI CRYSTALLINE DYSTROPHY trials appear

Gene therapy expands to second eye in rare vision loss trial